Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA approves first new drug for tuberculosis in 25 years

June 26, 1998

Another market introduction for cidofovir

June 25, 1998

Nabi licenses technology for development of antiviral drug

June 24, 1998

Substituted carbapenems for Gram-positive infections designed at Merck & Co.

June 24, 1998

Abbott patents improved ketolide antibacterial agents

June 24, 1998

Nyotran compared to free nystatin and amphotericin B formulations in vitro

June 23, 1998

FDA approves biotech product for RSV disease in children

June 22, 1998

New macrolide antibiotic derivatives from Pfizer

June 22, 1998

Novel trpS polypeptides/polynucleotides for the treatment of bacterial infections

June 19, 1998

Famvir cleared by FDA for treatment of herpes in HIV-positive individuals

June 18, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...